Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis: An Open-Label Trial

Overview of attention for article published in Archives of neurology (1960. Online), December 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 1 X user
wikipedia: 2 Wikipedia pages

guideline: 1 clinical guideline source

Readers on

mendeley: 91 Mendeley

So far, Altmetric has seen 1 X post from an account with 85,190 followers.

Doxycycline was beneficial for MS patients. Addition of doxy resulted in “reductions in contrast-enhancing lesion numbers and posttreatment Expanded Disability Status Scale values (P < .001 for both)” https://t.co/U5pGJnbdWE

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.